Tag Archives: Acerta Pharma

December, 2017

February, 2016

December, 2015

  • 18 December

    AstraZeneca to Acquire Majority Stake in Acerta Pharma in $4 Billion Deal

    OSS, TheNetherlands & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Acerta Pharma B.V. (Acerta), a clinical-stage biopharmaceutical company, announced today that it has entered into a definitive agreement with AstraZeneca whereby AstraZeneca will acquire a majority stake in Acerta. The transaction provides AstraZeneca with Acerta’s potential best-in-class irreversible oral Bruton’s tyrosine kinase (Btk) inhibitor, …